BARCLAYS PLC - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 1 filers reported holding VIRACTA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3
-25.0%
2,6680.0%0.00%
Q2 2023$40.0%2,6680.0%0.00%
Q1 2023$40.0%2,668
-3.0%
0.00%
Q4 2022$4
-100.0%
2,751
-43.2%
0.00%
Q3 2022$20,000
+100.0%
4,844
+81.6%
0.00%
Q2 2022$10,000
-75.6%
2,668
-68.8%
0.00%
Q1 2022$41,0008,5540.00%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
RP Management, LLC 3,700$13,505,0005.65%
Samsara BioCapital, LLC 711,039$2,595,0000.50%
BVF INC/IL 3,438,944$12,552,0000.46%
Aisling Capital Management LP 288,571$1,053,0000.37%
AlphaCentric Advisors LLC 90,000$329,0000.10%
HAMILTON LANE ADVISORS LLC 71,491$261,0000.03%
BOURGEON CAPITAL MANAGEMENT LLC 20,500$75,0000.02%
Jasper Ridge Partners, L.P. 92,939$339,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 32,651$119,0000.01%
Trexquant Investment LP 30,060$110,0000.01%
View complete list of VIRACTA THERAPEUTICS INC shareholders